F. Hoffmann-La Roche Ltd (manufacturing of unpackaged products, primary and secondary packaging, quality control testing, batch release)

Ukraine

All drugs from this manufacturer

  • MABTHERA

    The drug is used for the treatment of follicular non-Hodgkin lymphoma (both in combination with chemotherapy and for maintenance therapy), as well as for the treatment of CD20-positive diffuse large B-cell non-Hodgkin lymphoma.

    Dosage form: solution for injection

    Active substance Dosage
    rituximab 1400 mg/11.7 mL

    ATC: L01FA01